Abstract
The phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway is a key regulator of authophagy. Natural products show anticancer activity and often induce apoptosis or autophagy. The crosstalk between these two types of cell death makes autophagy an interesting target since drugs targeting this process not only can induce cell death by inducing autophagy but can also sensitize cells to apoptosis. Autophagy is also a protective mechanism associated with increased resistance to chemotherapy. In this review, we discuss natural products known to induce autophagy cell death in cancer cells via the PI3K/Akt/mTOR pathway.
Keywords: Natural products, PI3K/Akt, autophagy, cancer stem cell, stemness, cell death, anticancer drugs.
Anti-Cancer Agents in Medicinal Chemistry
Title:Natural Products Targeting Autophagy via the PI3K/Akt/mTOR Pathway as Anticancer Agents
Volume: 13 Issue: 7
Author(s): Hui Sun, Zhaoye Wang and Juan Sebastian Yakisich
Affiliation:
Keywords: Natural products, PI3K/Akt, autophagy, cancer stem cell, stemness, cell death, anticancer drugs.
Abstract: The phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway is a key regulator of authophagy. Natural products show anticancer activity and often induce apoptosis or autophagy. The crosstalk between these two types of cell death makes autophagy an interesting target since drugs targeting this process not only can induce cell death by inducing autophagy but can also sensitize cells to apoptosis. Autophagy is also a protective mechanism associated with increased resistance to chemotherapy. In this review, we discuss natural products known to induce autophagy cell death in cancer cells via the PI3K/Akt/mTOR pathway.
Export Options
About this article
Cite this article as:
Sun Hui, Wang Zhaoye and Yakisich Sebastian Juan, Natural Products Targeting Autophagy via the PI3K/Akt/mTOR Pathway as Anticancer Agents, Anti-Cancer Agents in Medicinal Chemistry 2013; 13 (7) . https://dx.doi.org/10.2174/18715206113139990130
DOI https://dx.doi.org/10.2174/18715206113139990130 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Rg1 Promotes the Proliferation and Adipogenic Differentiation of Human
Adipose-Derived Stem Cells <i>via</i> FXR1/Lnc-GAS5-AS1 Pathway
Current Stem Cell Research & Therapy Conventional and Gene Therapy Strategies for the Treatment of Brain Tumors
Current Medicinal Chemistry Cordycepin Downregulates Cdk-2 to Interfere with Cell Cycle and Increases Apoptosis by Generating ROS in Cervical Cancer Cells: in vitro and in silico Study
Current Cancer Drug Targets Biodistribution and Dosimetry of 177Lu-tetulomab, a New Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma
Current Radiopharmaceuticals Magnetic Resonance Nano-Theranostics for Glioblastoma Multiforme
Current Pharmaceutical Design Mitochondrial Drug Targets in Cell Death and Cancer
Current Pharmaceutical Design Gap Junctions as Targets for Cancer Chemoprevention and Chemotherapy
Current Drug Targets GIST and Breast Cancer: 3 Case Reports and a Review of the Literature
Current Cancer Therapy Reviews Application of a Deep Matrix Factorization Model on Integrated Gene Expression Data
Current Bioinformatics Role of ZEB Family Members in Proliferation, Metastasis, and Chemoresistance of Prostate Cancer Cells: Revealing Signaling Networks
Current Cancer Drug Targets Patent Selections
Recent Patents on Biomarkers Multifunctional Radiolabeled Nanoparticles for Targeted Therapy
Current Medicinal Chemistry Phytoestrogens and Mitochondrial Biogenesis in Breast Cancer. Influence of Estrogen Receptors Ratio
Current Pharmaceutical Design Electrochemical Cell-based Biosensors for Biomedical Applications
Current Topics in Medicinal Chemistry Lymphangiogenesis and Anti-Tumor Immune Responses
Current Molecular Medicine Bioactives in Disease Prevention and Health Promotion: Exploiting Combinatorial Effects
Current Bioactive Compounds Update on Evidence that Support a Role of Solar Ultraviolet-B Irradiance in Reducing Cancer Risk
Anti-Cancer Agents in Medicinal Chemistry The Role of COX-2 in Oral Cancer Development, and Chemoprevention/ Treatment of Oral Cancer by Selective COX-2 Inhibitors
Current Pharmaceutical Design uPAR as Anti-Cancer Target: Evaluation of Biomarker Potential, Histological Localization, and Antibody-Based Therapy
Current Drug Targets Oncotarget Strategies For Herpes Simplex Virus-1
Current Gene Therapy